Pharmacy Medicare Fraud
Polymedica paid $35 million to resolve allegations by our client, whistleblower Claire Schultz, that two of Polymedica’s pharmacy subsidiaries violated the False Claims Act by dispensing and billing Medicare for diabetic and nebulizer products without first obtaining a signed doctor’s order or prescription for the products.
For more information, see the DOJ press release about the settlement.
